Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
9,165,070
-
Share change
-
+229,986
-
Total reported value
-
$257,700,283
-
Put/Call ratio
-
387%
-
Price per share
-
$28.11
-
Number of holders
-
112
-
Value change
-
-$5,702,648
-
Number of buys
-
62
-
Number of sells
-
59
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q1 2022
As of 31 Mar 2022 ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) had 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,165,070 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, THOMPSON SIEGEL & WALMSLEY LLC, EMERALD ADVISERS, LLC, Global Alpha Capital Management Ltd., FIRST WILSHIRE SECURITIES MANAGEMENT INC, and AMERIPRISE FINANCIAL INC.
This table shows 113 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.